Cargando…
Lung cancer development in the patient with granulomatosis with polyangiitis during long term treatment with cyclophosphamide: first documented case
A 65‐year‐old man was diagnosed with granulomatosis with polyangiitis (GPA) at the age of 47, when cytoplasmic anti‐neutrophil cytoplasmic antibody (C‐ANCA) serology was positive, and he had multiple nodular shadows in both lungs. He had been treated with prednisolone, cyclophosphamide (CPA) and pla...
Autores principales: | Toriyama, Midori, Tagaya, Etsuko, Yamamoto, Tomoko, Kondo, Mitsuko, Nagashima, Yoji, Tamaoki, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756708/ https://www.ncbi.nlm.nih.gov/pubmed/29321928 http://dx.doi.org/10.1002/rcr2.284 |
Ejemplares similares
-
Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021) -
Comparison of tumor cell numbers and 22C3 PD-L1 expression between cryobiopsy and transbronchial biopsy with endobronchial ultrasonography-guide sheath for lung cancer
por: Arimura, Ken, et al.
Publicado: (2019) -
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis
por: Puéchal, Xavier, et al.
Publicado: (2022) -
Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis
por: Sheehy, Robert, et al.
Publicado: (2015) -
A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
por: Okude, Azusa, et al.
Publicado: (2012)